首頁 > 市場調查報告書 > 醫療設備

生技設備

全EXOME市場規模、佔有率和成長分析（按產品、技術、工作流程、應用、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1897358

全EXOME市場規模、佔有率和成長分析（按產品、技術、工作流程、應用、最終用戶和地區分類）－2026-2033年產業預測

Whole Exome Sequencing Market Size, Share, and Growth Analysis, By Product, By Technology, By Workflow, By Application, By End-use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月26日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球全EXOME定序市場規模預計在 2024 年達到 5.8334 億美元，從 2025 年的 6.8484 億美元成長到 2033 年的 24.7135 億美元，在預測期（2026-2033 年）內複合年成長率為 17.4%。

全球全EXOME定序市場正經歷顯著成長，這主要得益於技術進步、在研究和診斷領域應用範圍的擴大以及成本的下降。對精準快速檢測遺傳性疾病和慢性病的需求日益成長，推動了該行業的擴張，醫療專業人員擴大利用全EXOME子組測序來發現與各種疾病相關的基因突變。這項技術能夠根據個體的基因組特徵制定個人化治療方案。隨著這些技術的普及和成本效益的提高，醫療機構對其的採用率也不斷上升。以特定基因標記為基礎的個人化醫療趨勢，代表著該行業一條充滿前景的發展道路，而持續的技術創新有望進一步提升醫療保健領域的診斷能力和治療策略。

推動全球全外EXOME定序發展的因素

推動全球全EXOME序市場擴張的關鍵因素之一是人們對個人化醫療日益成長的需求。透過分析個體的全EXOME，醫療服務提供者可以根據每位患者獨特的基因譜和疾病易感性制定個人化的治療方案。這種客製化方法能夠提高治療效果，最終改善患者的預後。此外，定序技術和數據分析的不斷進步使得全EXOME定序越來越普及且成本更低，從而促進了其在臨床上的應用。隨著個人化醫療的重要性日益凸顯，對全EXOME定序的需求將持續成長，並對醫療保健格局產生深遠影響。

限制全球全EXOME定序市場

全EXOME定序市場面臨巨大的挑戰，這主要是由於其產生的大量基因組數據具有複雜度和解讀難度。分析和解讀這些龐大的遺傳訊息通常耗時費力，並且需要專業知識。此外，確保結果的準確性和可靠性對於做出明智的醫療決策至關重要。這需要先進的生物資訊學工具和專業知識來有效管理和解讀數據，而這些因素可能會阻礙全外EXOME子定序的廣泛應用。這些限制最終可能會限制其在各種醫療保健環境中的可用性和實際應用。

全球全外EXOME定序市場趨勢

人工智慧 (AI) 和機器學習 (ML) 技術在資料分析和解讀過程中的融合是全球全EXOME定序市場的一大趨勢。這些先進的分析工具正被擴大用於管理全外EXOME定序產生的大量基因組數據，從而能夠識別重要的遺傳模式、突變和疾病關聯。透過自動化數據處理和提高準確性，AI 和 ML 正在改變基因組分析的格局，實現更快、更準確地檢測基因突變。這種整合不僅有助於提高診斷準確性和個人化治療方案，還促進了基因組醫學的發展，從而顯著推動了全EXOME序市場的成長。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Illumina, Inc.（USA）
Thermo Fisher Scientific, Inc.（USA）
Agilent Technologies, Inc.（USA）
Pacific Biosciences of California, Inc.（PacBio）（USA）
Oxford Nanopore Technologies plc.（UK）
BGI Genomics Co., Ltd.（China）
Eurofins Scientific SE（Luxembourg）
Bio-Rad Laboratories, Inc.（USA）
Novogene Co., Ltd.（China）
Azenta, Inc.（formerly GENEWIZ）（USA）
CD Genomics（USA）
Psomagen, Inc.（South Korea）
F. Hoffmann-La Roche AG（Switzerland）
10x Genomics, Inc.（USA）
Bionano Genomics, Inc.（USA）
Dante Labs（Italy）
MGI Tech Co., Ltd.（China）
GeneDx Holdings Corp.（USA）
Helix OpCo, LLC（USA）

結論與建議

簡介目錄

Product Code: SQMIG35H2119

Global Whole Exome Sequencing Market size was valued at USD 583.34 Million in 2024 and is poised to grow from USD 684.84 Million in 2025 to USD 2471.35 Million by 2033, growing at a CAGR of 17.4% during the forecast period (2026-2033).

The global market for whole exome sequencing is experiencing notable growth driven by advancements in technology, expanding applications in research and diagnostics, and decreasing costs. The rising demand for accurate and timely detection of genetic and chronic diseases has accelerated industry expansion, with healthcare professionals increasingly leveraging whole exome sequencing to uncover genetic variations linked to various conditions. This capability facilitates the development of personalized treatments tailored to individual genomic profiles. As such technologies become more accessible and cost-effective, healthcare facilities are adopting them at higher rates. The trend towards personalized medicine, where treatment is based on specific genetic markers, indicates a promising trajectory for the industry, with ongoing innovations likely to further enhance diagnostic capabilities and therapeutic strategies in healthcare.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Whole Exome Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Whole Exome Sequencing Market Segments Analysis

Global Whole Exome Sequencing Market is segmented by Product, Technology, Workflow, Application, End-use and region. Based on Product, the market is segmented into Instruments, Consumables, System, Kits and Services. Based on Technology, the market is segmented into Sequencing by Synthesis, ION Semiconductor Sequencing and Others. Based on Workflow, the market is segmented into Pre-Sequencing, Sequencing and Data Analysis. Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development, Personalized Medicines, Agriculture and Animal Research and Others. Based on End-use, the market is segmented into Academic And Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Whole Exome Sequencing Market

A significant factor contributing to the expansion of the global whole exome sequencing market is the rising demand for personalized medicine. By analyzing an individual's entire exome, healthcare providers can tailor treatment plans to align with each patient's unique genetic profile and vulnerability to diseases. This customized approach enhances the effectiveness of therapies, ultimately leading to better patient outcomes. Additionally, continuous advancements in sequencing technologies and data analysis are making whole exome sequencing increasingly accessible and cost-effective, thereby promoting its utilization in clinical environments. As the importance of individualized healthcare becomes more recognized, the demand for whole exome sequencing continues to grow, influencing the healthcare landscape.

Restraints in the Global Whole Exome Sequencing Market

The whole exome sequencing market encounters notable challenges due to the complexity and interpretation difficulties linked to the substantial volumes of genomic data produced. The analysis and interpretation of this extensive genetic information are often time-intensive and demand specialized knowledge. Furthermore, guaranteeing the accuracy and reliability of results is vital for informed medical decision-making. This necessitates the availability of advanced bioinformatics tools and expertise to effectively manage and interpret the data, which can hinder the widespread adoption of whole exome sequencing. Such constraints can ultimately limit its accessibility and practical application within various healthcare environments.

Market Trends of the Global Whole Exome Sequencing Market

The Global Whole Exome Sequencing market is experiencing a notable trend with the incorporation of artificial intelligence (AI) and machine learning (ML) technologies into data analysis and interpretation processes. These advanced analytical tools are increasingly utilized to manage the vast amounts of genomic data generated from whole exome sequencing, enabling the identification of crucial genetic patterns, variations, and disease correlations. By automating data processing and enhancing accuracy, AI and ML are changing the landscape of genomic analysis, leading to more rapid and precise detection of genetic variants. This integration not only supports improved diagnoses and personalized treatment options but also propels advancements in genomic medicine, positioning the whole exome sequencing market for significant growth.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Whole Exome Sequencing Market Size by Product & CAGR (2026-2033)

Market Overview
Instruments
Consumables
System
Kits
Services

Global Whole Exome Sequencing Market Size by Technology & CAGR (2026-2033)

Market Overview
Sequencing by Synthesis
ION Semiconductor Sequencing
Others

Global Whole Exome Sequencing Market Size by Workflow & CAGR (2026-2033)

Market Overview
Pre-Sequencing
Sequencing
Data Analysis

Global Whole Exome Sequencing Market Size by Application & CAGR (2026-2033)

Market Overview
Clinical Diagnostics
Drug Discovery & Development
Personalized Medicines
Agriculture and Animal Research
Others

Global Whole Exome Sequencing Market Size by End-use & CAGR (2026-2033)

Market Overview
Academic And Research Institutes
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others

Global Whole Exome Sequencing Market Size & CAGR (2026-2033)

North America (Product, Technology, Workflow, Application, End-use)
- US
- Canada
Europe (Product, Technology, Workflow, Application, End-use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Technology, Workflow, Application, End-use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Technology, Workflow, Application, End-use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Technology, Workflow, Application, End-use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Illumina, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pacific Biosciences of California, Inc. (PacBio) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oxford Nanopore Technologies plc. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BGI Genomics Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific SE (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novogene Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Azenta, Inc. (formerly GENEWIZ) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CD Genomics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Psomagen, Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
10x Genomics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bionano Genomics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dante Labs (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MGI Tech Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GeneDx Holdings Corp. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Helix OpCo, LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments